GCGR and Hyperglycemia: Thus, the alteration of EGP and glycemia by treatment with GCGR blockers may not provide definitive proof as to whether hyperglucagonemia plays a dominant role in the inappropriately elevated postabsorptive EGP and hyperglycemia in patients with T2DM.